spacer
home > pmps > summer 2002 > drying technology - soft capsule manufacturing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Drying Technology - Soft Capsule Manufacturing

Soft and Hard Capsules

The manufacturing of hard and soft gelatine capsules is an exacting operation that requires specific conditions to ensure the highest quality of the final product. Some of the many variables that must be dealt with include: gelatine concentration and viscosity; air temperature and humidity; lubrication of pins; stripping and cutting of capsules; inspection and sorting. When the ideal combination of all these factors is met, an acceptable, good quality capsule is produced.
Among these specific variables, manufacturers must deal with air, specifically in terms of temperature and humidity. Proper humidity control is essential during the manufacturing and drying of hard and soft capsules. Air goes directly onto the product and the quality and relative humidity of the air is extremely important.

It is essential to maintain the humidity as closely as possible to the required space conditions with very little variation, as variation in the humidity can cause a variety of problems. Under high humidity conditions, gelatine capsules do not dry properly; in an atmosphere that is too dry, they become hard and brittle. Ideal conditions are consistent humidity and temperature control.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Ing. Koen Egberts, International Sales Manager for Kathabar Systems Ing. Koen Egberts studied mechanical engineering at the High Technical School in Utrecht. After completing his degree he worked for several years at Asea Brown Boveri (ABB). He was responsible for the engineering and sales of the ABB Flдkt climate control systems.
Since 1998 he has held the position of International Sales Manager for Kathabar Systems Europe, a division of Imtech.

spacer
Ing. Koen Egberts
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Introduces New Integrated Plug & Play Upstream Development Service

Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-up Tailored upstream development from a single source reduces time to clinic by 20 percent Fast-track process reduces timeline by 10 weeks for first pharmacodynamic experiment
More info >>

White Papers

Biosimilars In Emerging Markets: Is It A Level Playing Field?

PRA Health Sciences (PRA)

Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement